News | October 17, 2006

Hayes Inc., an independent health technology assessment company, has completed a comprehensive comparison of five gadolinium-based contrast media for magnetic resonance imaging (MRI) applications. The report provides an evidence-based assessment of the diagnostic performance and comparative safety profiles of MultiHance vs. Magnevist, Omniscan, OptiMARK and ProHance.
The comparison found that MultiHance (gadobenate dimeglumine) exhibits a higher relaxivity in plasma, which may provide better image quality and diagnostic performance than other gadolinium-based contrast agents for certain organs, including the central nervous system, liver, kidneys and breasts.


Additional Content

News | Information Technology

Oct. 27, 2026 — Altamont Software recently announced that CaptureWare Video, its enterprise medical video capture ...

Time October 29, 2026
arrow
News | Radiology Imaging

May 26, 2026 — Leica Biosystems and Indica Labs have announced a strategic collaboration with Lunit to develop AI ...

Time May 26, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

January 15, 2024 — MRI simulation software leader ScanLabMR announced the release of UltraLab, a breakthrough software ...

Time January 15, 2024
arrow
News | HIMSS

July 1, 2021 — If you are traveling to HIMSS21 in August, be sure to note that the Healthcare Information and Management ...

Time July 01, 2021
arrow
News | Information Technology

April 16, 2021 — The U.S. Food and Drug Administration (FDA) issued the final rule: Medical Device Classification ...

Time April 16, 2021
arrow
Subscribe Now